ImmUnion

ImmUnion

Biotechnologieforschung

Connecting to Patients own Immunity

Info

ImmUnion developed the ImmunoTag, an innovative molecule able to recruit the anti-tetanus antibodies and use them to fight life-threatening diseases. We have two products under development: 1) VacciTag™: ImmunoTag addition to vaccines speeds-up the immunization process; 2) ImmunoJunction™: ImmunoTag combination with an antibody fragment redirects anti-tetanus antibodies against a virus to eradicate an infection.

Branche
Biotechnologieforschung
Größe
2–10 Beschäftigte
Hauptsitz
Potsdam
Art
Privatunternehmen

Orte

Beschäftigte von ImmUnion

Ähnliche Seiten

Jobs durchsuchen